Genprex, Inc. (GNPX)
1.98
-0.09
(-4.35%)
USD |
NASDAQ |
Mar 05, 16:00
2.00
+0.02
(+1.01%)
After-Hours: 20:00
Genprex EPS Diluted (Quarterly) : -4.996 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.799M |
| Total Expenses (Quarterly) | 3.799M |
| Enterprise Value | 3.596M |
| Earnings Yield | -1.76K% |
| Normalized Earnings Yield | -1764.58 |